Minimal residual disease cells in AML patients have an apoptosis-sensitive protein profile
- 5 February 2004
- journal article
- other
- Published by Springer Nature in Leukemia
- Vol. 18 (4) , 875-877
- https://doi.org/10.1038/sj.leu.2403299
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Multiparameter flow cytometric quantification of apoptosis-related protein expressionLeukemia, 2003
- A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemiaLeukemia, 2003
- Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML)Blood, 2003
- Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteinsLeukemia, 2002
- Functional characterization of minimal residual disease for P-glycoprotein and multidrug resistance protein activity in acute myeloid leukemiaLeukemia, 2001
- Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratificationBlood, 2001
- High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapyBlood, 1993